Treatment effects of familact Probiotic in Non Alcoholic Fatty Liver Disease(NAFLD)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014112019554N2

Enrollment

Registered

2015-07-12

Start date

2015-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic steatohepatitis. Other specified inflammatory liver diseases, Nonalcoholic steatohepatitis [NASH]

Interventions

Intervention 1: Daily exercise for at least 30 minutes. Intervention 2: Familact capsule 500 mg once daily after a meal.

Lifestyle

Treatment - Drugs

Daily exercise for at least 30 minutes

Familact capsule 500 mg once daily after a meal

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with NAFLD on ultrasonography; ALT more than 1.5 to 5 times the normal range; BMI between 25 to 29.9 Exclusion criteria: alcoholic hepatitis; systemic or metabolic or inflammatory disease such as diabetes; viral hepatitis; autoimmune hepatitis; secondary fatty liver disease such as drug induced fatty liver disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: at the first and after 8 weeks. Method of measurement: Manometer.;Body mass index. Timepoint: at the first and after 8 weeks. Method of measurement: Analog scale, Meter.;Fasting blood glucose. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;Total cholestrol. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;LDL. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;HDL?. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;TG. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;AST. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;ALT. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.	—

Measure

Time frame

Blood pressure. Timepoint: at the first and after 8 weeks. Method of measurement: Manometer.;Body mass index. Timepoint: at the first and after 8 weeks. Method of measurement: Analog scale, Meter.;Fasting blood glucose. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;Total cholestrol. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;LDL. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;HDL?. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;TG. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;AST. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.;ALT. Timepoint: at the first and after 8 weeks. Method of measurement: ELISA.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Maryam Jameshorani

Zanjan University of Medical Sciences

dr.shirinjameshorani@yahoo.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026